PRESS RELEASE published on 08/31/2026 at 07:00, 2 months 14 days ago PolyPeptide Group: Samsung Peptide AG publishes offer prospectus for public tender offer for PolyPeptide Group AG Samsung Peptide AG publishes offer prospectus for public tender offer for PolyPeptide Group AG, valued at approximately CHF 1.46 billion. The Board of Directors of PolyPeptide recommends accepting the Offer Board Of Directors Public Tender Offer PolyPeptide Group Offer Prospectus Samsung Peptide AG
BRIEF published on 08/13/2026 at 07:05, 3 months 1 day ago PolyPeptide annonce une forte croissance au premier semestre 2026 et met à jour ses perspectives pour l'exercice complet. Perspectives À Moyen Terme Croissance Des Revenus Amélioration De L'EBITDA Extension De Capacité Thérapeutiques Métaboliques
BRIEF published on 08/13/2026 at 07:05, 3 months 1 day ago PolyPeptide Reports Robust H1 2026 Growth and Updates Full-Year Outlook Revenue Growth Capacity Expansion EBITDA Improvement Mid-term Outlook Metabolic Therapeutics
PRESS RELEASE published on 08/13/2026 at 07:00, 3 months 1 day ago PolyPeptide delivers +42% growth in H1 2026 and improved EBITDA margin; 2026 full-year guidance updated, now expecting 25-30% revenue growth and high-teens EBITDA margin PolyPeptide Group announces strong H1 2026 results: +42% revenue growth and improved EBITDA margin. 2026 full-year guidance raised to 25-30% growth and high-teens EBITDA margin Revenue Growth EBITDA Margin PolyPeptide Group Full-year Guidance H1 2026
BRIEF published on 07/20/2026 at 00:50, 3 months 26 days ago Offre publique d'achat de Samsung Biologics sur PolyPeptide Group Résultats Financiers Offre Publique D'achat Stratégie D'acquisition Samsung Biologics Croissance Des Polypeptides
BRIEF published on 07/20/2026 at 00:50, 3 months 26 days ago Samsung Biologics' Tender Offer for PolyPeptide Group Financial Results Tender Offer Acquisition Strategy PolyPeptide Growth Samsung Biologics
PRESS RELEASE published on 07/20/2026 at 00:45, 3 months 26 days ago PolyPeptide Group: Samsung Biologics announces tender offer to acquire PolyPeptide Group AG for CHF 44.31 per share Samsung Biologics announces tender offer to acquire PolyPeptide Group AG at CHF 44.31 per share, reflecting growth and profitability. PolyPeptide reports marked acceleration in H1 2026 results Profitability Growth Tender Offer PolyPeptide Group AG Samsung Biologics
BRIEF published on 04/14/2026 at 07:05, 7 months ago PolyPeptide Group observe les spéculations du marché concernant une potentielle prise de contrôle Croissance Des Revenus Revue Stratégique Groupe Polypeptide Spéculation Du Marché Intérêt Pour La Prise De Contrôle
BRIEF published on 04/14/2026 at 07:05, 7 months ago PolyPeptide Group Observes Market Speculation Regarding Potential Takeover Revenue Growth Strategic Review PolyPeptide Group Market Speculation Takeover Interest
PRESS RELEASE published on 04/14/2026 at 07:00, 7 months ago PolyPeptide Group AG takes note of market rumors and speculation PolyPeptide Group AG acknowledges market rumors and speculation regarding potential takeover interest, conducting a review of strategic options in coordination with majority shareholder Draupnir Holding B.V Strategic Options PolyPeptide Group Shareholder Review Market Rumors Takeover Interest
Published on 11/14/2026 at 12:56, 15 hours 42 minutes ago Gabriel Announces Dismissal of ICSID Annulment Application
Published on 11/14/2026 at 01:30, 1 day 3 hours ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 1 day 3 hours ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 1 day 4 hours ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 1 day 4 hours ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:24, 1 day 5 hours ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 1 day 6 hours ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 1 day 9 hours ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 1 day 9 hours ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 11:35, 1 day 17 hours ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 1 day 17 hours ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 1 day 20 hours ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 2 days 5 hours ago Belgrano continues the implementation of its public share buyback offer (OPRA)